Clinical trial
Risk-Adapted Therapy for Pediatric Hodgkin's Disease
NCT00145600 is registered in ClinicalTrials.gov with St. Jude Children's Research Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Risk-Adapted Therapy for Pediatric Hodgkin's Disease
- Lead sponsor
- St. Jude Children's Research Hospital
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- March 2, 2000
- Completion date
- November 5, 2021
- Enrollment
- 296 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
hodgkin lymphoma